Home/Pipeline/Autism Tablet

Autism Tablet

Autism

Phase IIActive

Key Facts

Indication

Autism

Phase

Phase II

Status

Active

Company

OFD Biopharma

About OFD Biopharma

OFD Biopharma, a division of OFD Life Sciences, is a US-based CDMO providing expert lyophilization solutions to stabilize complex pharmaceuticals. The company differentiates itself through its focus on bulk lyophilization and proprietary platforms like LyoLock and LyoPastille, which aim to enhance drug stability, solubility, and bioavailability. It offers end-to-end support from R&D through commercialization, serving clients in oncology, immunology, and other therapeutic areas. As a private service provider, its financial model is based on client contracts and project milestones.

View full company profile

Therapeutic Areas

Oncology Immunology Infectious Disease Gastrointestinal Central Nervous System

Other Autism Drugs

Drug	Company	Phase	Status
UCT-MSC + Biomaterials	Vitti Labs	Phase 2	Active
UC-Blood Biomolecules	Vitti Labs	Phase 2	Active
Arfolitixorin	Isofol Medical	Pre-clinical / Discovery	Active
Autism Biomarker Services	The Siesta Group	Service Offering	Active
StroMel™ (Planned)	Akan Biosciences	Planned	Active